New Therapies for Hepatitis C Virus

1. Hepatitis C. WHO. Available at: www.who.int/mediacentre/factsheets/fs164/en/. Accessed October 1, 2015.Search in Google Scholar

2. SC Rey and DL Thomas. "Hepatitis C" (Chapter 156). In Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, edited by JE Bennett, R Dolin, MJ Blaser. Philadelphia: Elsevier, 2015.Search in Google Scholar

3. American Association for the Study of Liver Diseases/ Infectious Diseases Society of America/International Antiviral Society-USA. HCV Guidance: Recommendations for testing, managing, and treating hepatitis C. Available at: www.hcvguidelines.org. Accessed October 1, 2015.Search in Google Scholar

4. JM Pawlotsky et al. From non-A, non-B hepatitis to hepatitis C virus cure. J Hepatol. 2015; 62: S87.10.1016/j.jhep.2015.02.00625920094Search in Google Scholar

5. EASL Recommendations on treatment of Hepatitis C 2015. J Hepatol 2015; 63: 199..10.1016/j.jhep.2015.03.02525911336Search in Google Scholar

6. Telaprevir (Incivek) and Boceprevir (Victrelis) for Chronic Hepatitis C. Med Lett Drugs Ther. 2011; 53: 57.Search in Google Scholar

7. Drugs for Hepatitis C. Med Lett Drugs Ther. 2012; 54: 81.Search in Google Scholar

8. Simeprevir (Olysio) for Chronic Hepatitis C. Med Lett Drugs Ther. 2014; 56: 1.Search in Google Scholar

9. Sofosbuvir (Sovaldi) for chronic hepatitis C. Med Lett Drugs Ther. 2014; 56: 5.Search in Google Scholar

10. A Combination of Ledipasvir and Sofosbuvir (Harvoni) for Hepatitis C. Med Lett Drugs Ther. 2014; 56: 112.Search in Google Scholar

11. A 4-Drug Combination (Viekira Pak) for Hepatitis C. Med Lett Drugs Ther. 2015; 57: 15.Search in Google Scholar

12. Daclatasvir (Daklinza) for HCV Genotype 3 Infection. Med Lett Drugs Ther. 2015; 57: 142.Search in Google Scholar

13. In brief: severe bradycardia with sofosbuvir and amiodarone. Med Lett Drugs Ther. 2015; 57: 58.Search in Google Scholar

14. JM Collins et al. Hepatitis B virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir. Clin Infect Dis. 2015; 61: 130410.1093/cid/civ47426082511Search in Google Scholar

15. SD Safran. HIV coinfected have similar SVR rates as HCV monoinfected with DAAs: It's time to end segregation and integrate HIV patients into HCV trials. Clin Infect Dis. 2015; 61: 1127.10.1093/cid/civ43826060286Search in Google Scholar

16. SB Trooskin et al. Access to costly new hepatitis C drugs: medicine, money, and advocacy. Clin Infect Dis (2015) doi: 10.1093/cid/civ677 (First published online: August 12, 2015) 10.1093/cid/civ67726270682Search in Google Scholar